Drupal.behaviors.print = function(context) {window.print();window.close();}>
MDx/CDx Focus: Precision's ChemoFx Aids Development of Breast Cancer Response Predictors; Biocartis Launches DMAT
December 05, 2012
MDx/CDx Focus: Precision's ChemoFx Aids Development of Breast Cancer Response Predictors; Biocartis Launches DMAT
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Med BioGene's 2012 Revenues Drop to Zero, as it Awaits Launch of NSCLC Test
April 9, 2013 / GenomeWeb Daily News
Flemish Government Provides $2.5M to Biocartis to Develop Cancer Tests
February 25, 2013 / GenomeWeb Daily News
Dx Focus: Precision Therapeutics, Med BioGene LungExpress Dx; Hologic Prodesse ProGastro SSCS
January 24, 2013 / PCR Insider
Targeting Mid-Year LungExpress Dx Launch, Precision Readies Sales Force, Focuses on Reimbursement
January 23, 2013 / Pharmacogenomics Reporter
People in the News: Inge Basteleurs, John Hurrell
January 16, 2013 / Pharmacogenomics Reporter